Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 15, 2023

Trifluridine/Tipiracil in Patients With Metastatic Breast Cancer With or Without Prior Exposure to Fluoropyrimidines

European Journal of Cancer


Additional Info

European Journal of Cancer
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines
Eur. J. Cancer 2023 Nov 01;193(xx)113311, JSJ Lim, SGW Ow, ALA Wong, MXW Lee, GHJ Chan, JL Low, R Sundar, JRE Choo, WQ Chong, YLE Ang, BC Tai, SC Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading